[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-ivdr-erwgr-94-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":32,"citing_decisions":42,"is_thin":43},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"ivdr","über In-vitro-Diagnostika und zur Aufhebung der Richtlinie 98\u002F79\u002FEG und des Beschlusses 2010\u002F227\u002FEU der Kommission","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2025-02-11","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32017R0746",17343624,"ErwGr. 94","erwgr-94",null,"Erwägungsgründe","Der Kommission sollten Durchführungsbefugnisse übertragen werden, damit sie Zuteilungsstellen und EU-Referenzlaboratorien benennen kann.","IVDR - Erwägungsgründe - ErwGr. 94\n\nDer Kommission sollten Durchführungsbefugnisse übertragen werden, damit sie Zuteilungsstellen und EU-Referenzlaboratorien benennen kann.",{},[23,26,29],{"norm_key":24,"title":17,"slug":25},"ErwGr. 93","erwgr-93",{"norm_key":27,"title":17,"slug":28},"ErwGr. 92","erwgr-92",{"norm_key":30,"title":17,"slug":31},"ErwGr. 91","erwgr-91",[33,36,39],{"norm_key":34,"title":17,"slug":35},"ErwGr. 95","erwgr-95",{"norm_key":37,"title":17,"slug":38},"ErwGr. 96","erwgr-96",{"norm_key":40,"title":17,"slug":41},"ErwGr. 97","erwgr-97",[],true]